Statins Can Help Prevent Heart Disease in People with HIV— Are We Looking at the Right Risks?
Now, new findings from the REPRIEVE trial, presented at the CROI 2025 Conference, show that statins do help. The study also raises a big question: Are doctors using the right tests to find out who needs these drugs the most?
13 märts 2025 12:35
N6LS Antibody Brings Us Closer to Long-Acting HIV Treatment
Scientists have been exploring long-acting treatments that require fewer doses, while still keeping HIV in check. One promising option is VH3810109 (N6LS), a special type of antibody that fights the virus in a new way.
Lugege edasi
13 märts 2025 10:02
New Oral Islatravir/Doravirine Regimen Shows Strong Results in Two Phase 3 Studies
The studies, conducted by Merck & Co., Inc., suggest that switching to this new combination therapy is as effective as continuing with existing treatment regimens.
Lugege edasi
Mis on Life4me+?
Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine. Seepärast räägime HIVist ja muudest haigustest — sellest, kuidas end nende eest kaitsta ja kuidas elada nakatununa.
Rohkem
Kampaania Life4me+
Info haridusliku kampaania "M = M" kohta ("Mittetuvastatav = mitteedasikanduv", #UequalsU, #НравноН), mis on Life4me+ poolt organiseeritud Ida-Euroopas ja Kesk-Aasias regioonis, suunatud info levitamisele, et HIV-positiivne inimene mittetuvastatava viiruskoormusega ei saa viirust seksuaalsel teel edasi kanda teisele inimesele.
Mitmed uuringud on näidanud, et diskordantses paaris, kus HIV-positiive partner võtab ARV ravimeid ja hoiab viiruskoormuse mittetuvastataval tasemel, ei ole teada juhtumitest, kus HIV oleks seksuaalsel teel edasi kandunud.
Meie partnerid
